Wyeth, Impax Head To Court Over Effexor
Impax Laboratories was sued by Wyeth after it filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration. The suit was filed in the U.S. District Court for the District of Delaware.
Impax issued a statement calling the suit an attempt to block lower-priced medication from entering the market....
To view the full article, register now.